DeepMed Research

Alliance for Clinical Trials in Oncology

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2011-01-01

Employees: 251

Market Cap: -

Website: https://www.allianceforclinicaltrialsinoncology.org

Clinical Trials

Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer

Phase 3

Completed

Conditions: Osteoporosis
Breast Cancer

Interventions: Dietary Supplement: calcium salts
Dietary Supplement: cholecalciferol
Drug: zoledronic acid

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-19

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 439

Registration Number: NCT00022087

Locations: 🇺🇸
Kent General Hospital at Bayhealth Medical Center, Dover, Delaware, United States
🇺🇸
Galesburg Clinic, Galesburg, Illinois, United States
🇺🇸
Suniti Medical Corporation, Merrillville, Indiana, United States

and more 104 locations

Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer

Phase 3

Completed

Conditions: Breast Cancer
Colorectal Cancer

Interventions: Other: placebo
Drug: BenFin

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 88

Registration Number: NCT00026117

Locations: 🇺🇸
Mayo Clinic, Jacksonville, Florida, United States
🇺🇸
CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States
🇺🇸
CCOP - Duluth, Duluth, Minnesota, United States

and more 13 locations

Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women

Phase 3

Completed

Conditions: Hot Flashes

Interventions: Drug: medroxyprogesterone
Drug: venlafaxine

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 227

Registration Number: NCT00030914

Locations: 🇺🇸
Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
🇺🇸
Coborn Cancer Center, Saint Cloud, Minnesota, United States
🇺🇸
Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

and more 19 locations

Genetic Study in Patients With Stage II or Stage III Colon Cancer

Completed

Conditions: Colorectal Cancer

Interventions: Genetic: DNA stability analysis
Genetic: gene mapping

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-13

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 598

Registration Number: NCT00003833

Locations: 🇨🇦
British Columbia Cancer Agency, Vancouver, British Columbia, Canada
🇨🇦
Cape Breton Cancer Centre, Sydney, Nova Scotia, Canada
🇨🇦
Tom Baker Cancer Center - Calgary, Calgary, Alberta, Canada

and more 56 locations

Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

Phase 3

Completed

Conditions: Metastatic Cancer

Interventions: Radiation: radiation therapy
Procedure: surgery
Radiation: WBRT

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 480

Registration Number: NCT00030628

Locations: 🇺🇸
Comprehensive Cancer Center at Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Methodist Cancer Center at Methodist University Hospital, Memphis, Tennessee, United States
🇺🇸
American Fork Hospital, American Fork, Utah, United States

and more 34 locations

Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma

Completed

Conditions: Lymphoma

Interventions: Genetic: comparative genomic hybridization
Genetic: cytogenetic analysis
Genetic: fluorescence in situ hybridization
Genetic: gene rearrangement analysis

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 391

Registration Number: NCT00003863

Locations: 🇺🇸
Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, United States
🇺🇸
Veterans Affairs Medical Center - Chicago Westside Hospital, Chicago, Illinois, United States
🇺🇸
University of Chicago Cancer Research Center, Chicago, Illinois, United States

and more 66 locations

Surgery in Treating Patients With Prostate Cancer

Phase 2

Completed

Conditions: Prostate Cancer

Interventions: Procedure: conventional surgery

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 49

Registration Number: NCT00002938

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Cancer Institute at Memorial Regional Hospital, Hollywood, Florida, United States
🇺🇸
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States

and more 58 locations

Genetic Study of Young Patients With Colorectal Cancer

Completed

Conditions: Colorectal Cancer

Interventions: Genetic: microsatellite instability analysis

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-06

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 651

Registration Number: NCT00044967

Locations: 🇺🇸
Cancer Center at Creighton University Medical Center, Omaha, Nebraska, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
🇺🇸
Greenebaum Cancer Center at University of Maryland Medical Center, Baltimore, Maryland, United States

and more 70 locations

Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma

Not Applicable

Completed

Conditions: Melanoma (Skin)

Interventions: Genetic: comparative genomic hybridization
Genetic: cytogenetic analysis
Genetic: fluorescence in situ hybridization
Other: immunohistochemistry staining method

First Posted Date: 2003-01-27

Last Posted Date: 2016-07-01

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 314

Registration Number: NCT00049010

Locations: 🇺🇸
Ellis Fischel Cancer Center at University of Missouri - Columbia, Columbia, Missouri, United States
🇺🇸
Fletcher Allen Health Care - University Health Center Campus, Burlington, Vermont, United States
🇺🇸
Iowa Blood and Cancer Care, Cedar Rapids, Iowa, United States

and more 24 locations

Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma

Phase 2

Completed

Conditions: Malignant Mesothelioma

Interventions: Drug: epirubicin hydrochloride
Drug: gemcitabine hydrochloride

First Posted Date: 2003-01-27

Last Posted Date: 2016-12-07

Lead Sponsor: Alliance for Clinical Trials in Oncology

Target Recruit Count: 69

Registration Number: NCT00017186

Locations: 🇺🇸
CCOP - Mayo Clinic Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸
Rapid City Regional Hospital, Rapid City, South Dakota, United States
🇺🇸
CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States

and more 21 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy